Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events

T. Sehestedt*, S. Lyngbæk, J. Eugen-Olsen, J. Jeppesen, O. Andersen, T. W. Hansen, A. Linneberg, T. Jørgensen, S. B. Haugaard, M. H. Olsen

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    Objective: The soluble urokinase plasminogen activator receptor (suPAR) is a plasma marker of low grade inflammation and has been associated with cardiovascular risk. We wanted to investigate whether suPAR was associated with markers of subclinical organ damage. Methods: In a population sample of 2038 individuals, aged 41, 51, 61 and 71 years, without diabetes, prior stroke or myocardial infarction, not receiving any cardiovascular, anti-diabetic or lipid-lowering medications, we measured urine albumin/creatinine ratio (UACR), carotid atherosclerotic plaques and carotid/femoral pulse wave-velocity (PWV) together with traditional cardiovascular risk factors and high sensitivity C-reactive protein (hsCRP). Results: suPAR was significantly associated with the presence of plaques (P=0.003) and UACR (P<0.001), but not PWV (P=0.17) when adjusting for age, gender, systolic blood pressure, cholesterol, plasma glucose, waist/hip ratio, smoking and hsCRP. However, suPAR explained only a small part of the variation in the markers of subclinical organ damage (R2 0.02-0.04). During a median follow-up of 12.7 years (5th-95th percentile 5.1-13.4years) a total of 174 composite endpoints (CEP) of cardiovascular death, non-fatal myocardial infarction and stroke occurred. suPAR was associated with CEP independent of plaques, PWV, UACR, and hsCRP as well as age, gender, systolic blood pressure, cholesterol, plasma glucose, waist/hip ratio and smoking with a standardized hazard ratio of 1.16 (95% confidence interval 1.04-1.28, P=0.006). Conclusion: suPAR was associated with subclinical organ damage, but predicted cardiovascular events independent of subclinical organ damage, traditional risk factors and hsCRP. Further studies must investigate whether suPAR plays an independent role in the pathogenesis of cardiovascular disease.

    OriginalsprogEngelsk
    Sider (fra-til)237-243
    Antal sider7
    TidsskriftAtherosclerosis
    Vol/bind216
    Udgave nummer1
    DOI
    StatusUdgivet - 1 maj 2011

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events' indeholder.

    Citationsformater